Jack Lief
2012
In 2012, Jack Lief earned a total compensation of $4M as President, Chief Executive Officer and Director at Arena Pharmaceuticals, a 218% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $569,250 |
|---|---|
| Option Awards | $2,116,650 |
| Salary | $690,000 |
| Stock Awards | $532,200 |
| Other | $81,485 |
| Total | $3,989,585 |
Lief received $2.1M in option awards, accounting for 53% of the total pay in 2012.
Lief also received $569.3K in non-equity incentive plan, $690K in salary, $532.2K in stock awards and $81.5K in other compensation.
Rankings
In 2012, Jack Lief's compensation ranked 1,649th out of 11,487 executives tracked by ExecPay. In other words, Lief earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,649 out of 11,487 | 86th |
Division Manufacturing | 588 out of 4,253 | 86th |
Major group Chemicals And Allied Products | 131 out of 1,203 | 89th |
Industry group Drugs | 70 out of 925 | 92nd |
Industry Pharmaceutical Preparations | 59 out of 700 | 92nd |
Source: SEC filing on April 29, 2015.
Lief's colleagues
We found four more compensation records of executives who worked with Jack Lief at Arena Pharmaceuticals in 2012.